clinical resource center
No reported Sparrow Specialty Hospital caregiver or patient injury was reported during the 3 month study period and transfers averaged less than 4 minutes each.
SimPull has been determined a feasible primary means of lateral patient transfer. Following this study, The Patient Company was able to achieve the necessary regulatory approvals to proceed to bring SimPull to market commercially.
Interested in piloting SimPull at your facility? We are looking for teams that are passionate about improving employee and patient safety. If you, or someone you know may benefit by using SimPull in their clinical area, contact us.